Showing results (41-50 of 124) with videos related to
Sort By:
Pageof 13
Immunology and Cell Biology|April 1, 1993
Human natural killer (NK) cells: requirements for cell proliferation and expansion of phenotypically novel subpopulationsH S Warren, B F Kinnear, L J SkipseyThe Journal of Infectious Diseases|November 1, 1986
Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serumH S Warren, C V Knights, G R SiberThe Journal of Infectious Diseases|November 1, 1985
Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteriaG R Siber, S A Kania, H S WarrenAntimicrobial Agents and Chemotherapy|July 1, 1985
Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptideH S Warren, S A Kania, G R SiberThe Australian Journal of Experimental Biology and Medical Science|April 1, 1978
Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitroH S Warren, J A Woolnough, K J LaffertyBlood|October 1, 1984
Different colony-stimulating factors are detected by the "interleukin-3"-dependent cell lines FDC-Pl and 32D cl-23A J Hapel, H S Warren, D A HumeClinical Orthopaedics and Related Research|July 23, 1999
Omnifit cementless total hip arthroplasty. A 10-year average followupE J Hellman, W N Capello, J R FeinbergThe Iowa Orthopaedic Journal|January 1, 1996
When is total hip arthroplasty a failure? The patients' perspectiveE J Hellman, J R Feinberg, W N CapelloThe Journal of Arthroplasty|January 8, 1999
Nonunion of extended trochanteric osteotomies in impaction grafting femoral revisionsE J Hellman, W N Capello, J R FeinbergImmunology|February 1, 1988
The T11(3) epitope of the CD2 molecule, sheep erythrocytes, and the alternative T-cell activation pathwayH S Warren, V McPhun, A Bezos, et al.Pageof 13